» Articles » PMID: 9466463

Enhanced Expression of Metabotropic Glutamate Receptor 3 Messenger RNA in the Rat Spinal Cord During Ultraviolet Irradiation Induced Peripheral Inflammation

Overview
Journal Neuroscience
Specialty Neurology
Date 1998 Feb 18
PMID 9466463
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Metabotropic glutamate receptors are thought to play a role in the development and maintenance of spinal hyperexcitability resulting in hyperalgesia and pain. In this study we have used in situ hybridization to investigate the distribution of metabotropic glutamate receptors mGluR1-7 messenger RNA in the rat spinal cord in a model of inflammatory hyperalgesia. Hyperalgesia was induced in nine-day-old rats by exposure of the left hindpaw to an ultraviolet light source. Lumbar portions of spinal cords were removed from control and ultraviolet-treated animals. In situ hybridization with specific oligonucleotide probes was used to localize metabotropic glutamate receptor messenger RNAs. mGluR1, 3-5 and 7 subtype messenger RNA was detected in the gray matter of the spinal cord with distribution being specific for the different subtypes. A significant increase in the expression of mGluR3 messenger RNA was seen in cells of the dorsal laminae in both sides of the lumbar spinal cord. This increase was most pronounced in laminae II, III and IV but gradually decreased and disappeared by the third day of inflammation. In parallel with this, behavioural experiments revealed mechanical hyperalgesia in both hindlimbs after ultraviolet irradiation. There was no change in mGluR3 messenger RNA expression in the thoracic segments. No changes have been detected in the levels of expression of mGluR 1,2,4,5,7 subtype messenger RNA in spinal cords taken from hyperalgesic animals. These observations show that during ultraviolet irradiation induced inflammation, the synthesis of mGluR3 messenger RNA is altered suggesting that regulation of metabotropic glutamate receptor expression may be instrumental in plastic changes within the spinal cord during the development of hyperalgesia and pain.

Citing Articles

-Acetyl-Aspartyl-Glutamate in Brain Health and Disease.

Morland C, Nordengen K Int J Mol Sci. 2022; 23(3).

PMID: 35163193 PMC: 8836185. DOI: 10.3390/ijms23031268.


Broad spectrum efficacy with LY2969822, an oral prodrug of metabotropic glutamate 2/3 receptor agonist LY2934747, in rodent pain models.

Johnson M, Muhlhauser M, Nisenbaum E, Simmons R, Forster B, Knopp K Br J Pharmacol. 2017; 174(9):822-835.

PMID: 28177520 PMC: 5386998. DOI: 10.1111/bph.13740.


N-Acetyl-cysteine causes analgesia by reinforcing the endogenous activation of type-2 metabotropic glutamate receptors.

Bernabucci M, Notartomaso S, Zappulla C, Fazio F, Cannella M, Motolese M Mol Pain. 2012; 8:77.

PMID: 23088864 PMC: 3543227. DOI: 10.1186/1744-8069-8-77.


mGlu2 metabotropic glutamate receptors restrain inflammatory pain and mediate the analgesic activity of dual mGlu2/mGlu3 receptor agonists.

Zammataro M, Chiechio S, Montana M, Traficante A, Copani A, Nicoletti F Mol Pain. 2011; 7:6.

PMID: 21235748 PMC: 3030510. DOI: 10.1186/1744-8069-7-6.


The Role of Type 1 Metabotropic Glutamate Receptors in the Generation of Dorsal Root Reflexes Induced by Acute Arthritis or the Spinal Infusion of 4-Aminopyridine in the Anesthetized Rat.

Zhang L, Chen Y, Clark B, Sher E, Westlund K J Pain. 2011; 1(2):151-161.

PMID: 20882110 PMC: 2946106. DOI: 10.1016/S1526-5900(00)90100-7.